With the dramatic increase in the number of coronavirus disease 2019（COVID-19）cases worldwide since December 2019

hospitals across China have made major adjustments in the admission strategies for patients. On the one hand

the weakened immunity of patients with malignant tumors makes them a high-risk group of virus infection. On the other hand

for malignant tumor

as a special disease type

its surgical treatment needs to be completed within a time limit

which is unlikely to be delayed. Therefore

it is a great challenge for medical workers to carry out surgical treatment for such patients during the COVID-19 epidemic. As the largest tumor specialized hospital in southwest China

Sichuan Cancer Hospital still persisted in treating patients with malignant tumors while preventing and controlling the epidemic and has achieved good results. Taking the treatment of intermediate-to high-risk thyroid cancer patients in the First Ward Area of Head and Neck Surgery as an example

this article further summarizes the diagnosis and treatment process and experience of the Surgical Center in our hospital during the COVID-19 epidemic.